Invivyd (IVVD) Total Liabilities (2020 - 2025)
Invivyd (IVVD) posted Total Liabilities of $35.3 million for Q4 2025, down 23.32% on a QoQ basis from $46.1 million in Q3 2025, and down 42.97% year-over-year from $62.0 million in Q4 2024.
Invivyd (IVVD) Total Liabilities (2020 - 2025) Analysis & Trends
Invivyd's Total Liabilities history runs 6 years deep, the most recent figure standing at $35.3 million for Q4 2025.
- Quarterly Total Liabilities fell 42.97% year-over-year to $35.3 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $35.3 million (down 42.97% YoY) and the FY2025 annual result came in at $35.3 million, down 42.97% from the prior year.
- Total Liabilities was $35.3 million for Q4 2025 at Invivyd, down from $46.1 million in the prior quarter.
- Across five years, Total Liabilities topped out at $96.9 million in Q1 2022 and bottomed at $23.8 million in Q1 2023.
- A 5-year average of $48.6 million and a median of $46.3 million in 2025 frame the typical range for Total Liabilities.
- Annual changes were most pronounced in 2021 — Total Liabilities jumped 374.45% — and 2023, when it sank 75.42%.
- Invivyd's Total Liabilities stood at $62.1 million in 2021, then plunged by 56.18% to $27.2 million in 2022, then jumped by 90.14% to $51.7 million in 2023, then advanced by 19.85% to $62.0 million in 2024, then tumbled by 42.97% to $35.3 million in 2025.
- Business Quant data shows IVVD's Total Liabilities at $35.3 million in Q4 2025, $46.1 million in Q3 2025, and $46.3 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 60.46 Mn |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | 177.22 Mn |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 19.51 Mn |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 3.79 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 7.12 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 9.45 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | 15.48 Mn |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 1.62 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 753.82 Mn |
| 10 | Invivyd | 104.07 Mn | -122.62 Mn | 16.07 Mn | 35.34 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 35.34 Mn |
| Sep 30, 2025 | 46.09 Mn |
| Jun 30, 2025 | 46.35 Mn |
| Mar 31, 2025 | 49.60 Mn |
| Dec 31, 2024 | 61.98 Mn |
| Sep 30, 2024 | 78.76 Mn |
| Jun 30, 2024 | 36.70 Mn |
| Mar 31, 2024 | 36.97 Mn |
| Dec 31, 2023 | 51.71 Mn |
| Sep 30, 2023 | 28.42 Mn |
| Jun 30, 2023 | 33.85 Mn |
| Mar 31, 2023 | 23.82 Mn |
| Dec 31, 2022 | 27.20 Mn |
| Sep 30, 2022 | 47.30 Mn |
| Jun 30, 2022 | 69.77 Mn |
| Mar 31, 2022 | 96.88 Mn |
| Dec 31, 2021 | 62.07 Mn |
| Sep 30, 2021 | 53.06 Mn |
| Jun 30, 2021 | 37.91 Mn |
| Dec 31, 2020 | 13.08 Mn |